High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru

Author:

Toledo Angie K.ORCID,León-Jimenez Franco,Cavalcanti Sofia,Vilchez-Barreto Percy,Reto Narcisa,Vega Jessica,Bolivar Lucia M,Rhor Matilde,Ypanaque Jhon,Silva Henry,Moyano Luz M.,

Abstract

AbstractBackgroundDue to more infections from variations that could escape vaccination and immunity by asymptomatic to uninfected transmission, COVID-19’s second wave had higher seroprevalence globally. Public health constraints and herd immunity may not work against these novel variations’ infectivity. This population-based study in Peru’s Tumbes Region during the second wave of COVID-19 seeks to determine seroprevalence and demographic changes from the first wave.Methodology/Principal findingsIn Dec 2021-Jan 2022, a study in Tumbes’ informal settlement sampled individuals over 2 years old from one in every four households. Finger-prick blood samples and symptom surveys were collected. On the second wave, there was a substantial rise in adjusted seroprevalence (50.15%, 95% CI [45.92 – 54.40]) compared with the first wave (24.82 %, 95%CI [22.49 – 27.25]), with females maintaining a higher seroprevalence (53.89; 95% CI [48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compare to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave.Conclusions/SignificanceIn Tumbes, the seroprevalence of COVID-19 increased by twofold compared to the initial wave. Inadequate infrastructure and limitations in human resources and supplies in healthcare facilities made the Peruvian health system collapse. We must include in epidemiological surveillance mHealth tools that enable real-time reporting of new cases. Working alongside the community is the only way to improve any new intervention strategy to prevent or control a new pandemic.Author summaryIn Peru, the healthcare system was overwhelmed by the COVID-19 pandemic due to the lack of hospital capacity, oxygen supply, political unrest, and a fragmented healthcare system. During the first wave, the prevalence ranged from 20.8% to 72%, and it was predicted that the second wave would be disastrous. To assess the seroprevalence of SARS-CoV-2, a cross-sectional study was conducted in the settlement “AAHH Las Flores” located in front of Tumbes National University’s main campus. A door-to-door intervention was conducted, and a total of 580/781 (74.26%) individuals over than 2 years and above agreed to participate. After adjusting for sensitivity and specificity, the calculated adjusted seroprevalence was 50.15%. Women had a slightly higher adjusted seroprevalence compared to men, and the age groups with the highest prevalence of IgG seropositive were from 12 to 17 years, from 30 to 59 years, and older than 60 years. More than 80% of seropositive patients were asymptomatic in all age groups. The study’s findings suggest that COVID-19 transmission in the settlement was higher during the second wave, and asymptomatic individuals could have played a critical role in spreading the virus.

Publisher

Cold Spring Harbor Laboratory

Reference41 articles.

1. Some lessons that Peru did not learn before the second wave of COVID-19;Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, et al;Int J Health Plann Manage. mayo de,2021

2. Los tsunamis por Covid-19 en Perú: El primero malo, segundo peor;Mayta-Tristán P;Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo. julio de,2021

3. What does COVID-19 tell us about the Peruvian health system? Canadian Journal of Development Studies / Revue canadienne d’;tudes du développement,2021

4. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos;Álvarez-Antonio C, Meza-Sánchez G, Calampa C, Casanova W, Carey C, Alava F, et al;Peru in July and August, 2020: a population-based study. The Lancet Global Health. 1 de julio de,2021

5. Vargas-Herrera N, Araujo-Castillo RV, Mestanza O, Galarza M, Rojas-Serrano N, Solari-Zerpa L. SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence. The Lancet Regional Health – Americas [Internet]. 1 de febrero de 2022 [citado 16 de febrero de 2023];6. Disponible en: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00108-3/fulltext

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3